Why Leukocare
Why Leukocare
Leukocare at a Glance
Leukocare at a Glance
20 years of experience. Data-driven strategies. Trusted by biotech, mid-size pharma, and global leaders.
From AI-guided excipient prediction over formulation development to predictive stability modeling, we turn antibodies, viruses and viral vectors and other complex ATMPs into stable products. Please also change this in Michael´s quote on our mission on that website





Partner with Leukocare for tailored, data‑driven solutions that bring your biologics closer to patients.
Let’s Build the Right Formulation — Together

Partner with Leukocare for tailored, data‑driven solutions that bring your biologics closer to patients.
Let’s Build the Right Formulation — Together
Tailored for Complex Modalities - Expertise across antibodies, bispecifics, ADCs, peptides, viral vectors, and vaccines — with proven success in long-term stabilizing formulations and adjacent services.
Data-Science Powered Decisions - Data-driven designs predict excipients, flag risks, and lead into a targeted development — reducing trial‑and‑error and material use
Trusted by Biotech and Global Pharma - 150+ projects in the last three years delivered for biotech, mid‑size pharma, and leading global players - who rely on us for our scientific rigor, proven track record, and collaborative mindset.
Manufacturability & administrability - We analyze adsorption, pH-jump effects, high-concentration viscosity and container-closure interactions to ensure that what looks feasible in silico also works in practice. This step bridges stability with usability.
Related service: Primary Packaging Assessment
Tailored for Complex Modalities
Tailored for Complex Modalities
Leukocare is your partner for drug product development of sterile injectables, combining deep expertise in formulation with a comprehensive set of services to accelerate and de-risk your program.
Beyond formulation development, we provide developability assessments, in-use stability studies, particle characterization, and process development, ensuring every aspect of your product is designed for stability, manufacturability, and patient use. Our scientists bring broad experience across antibodies, bispecifics, ADCs, peptides, small molecules and viral vectors, and vaccines, delivering solutions tailored to the unique needs of each modality.
Leukocare is your partner for drug product development of sterile injectables, combining deep expertise in formulation with a comprehensive set of services to accelerate and de-risk your program.
Beyond formulation development, we provide developability assessments, in-use stability studies, particle characterization, and process development, ensuring every aspect of your product is designed for stability, manufacturability, and patient use. Our scientists bring broad experience across antibodies, bispecifics, ADCs, peptides, small molecules and viral vectors, and vaccines, delivering solutions tailored to the unique needs of each modality.


Data Science Powered Decisions
For more than 10 years, Leukocare has built its drug product development approach on data science and data integrity. This foundation ensures that our work is not only innovative but also reliable.
We apply bioinformatics to identify risks such as aggregation and to guide excipient choices, while biostatistics is embedded throughout the process — from method establishment and analytical evaluation to designing statistically sound DoE studies and predicting shelf life with confidence. This integrated approach reduces trial and error, conserves valuable material, and accelerates development timelines by delivering conclusive, data‑driven results.









Trusted by Biotech and Pharma
Over the last years, we have successfully delivered more than 150 development projects for biotech companies, mid‑size pharmaceutical firms, and leading global players. Clients value our ability to adapt to evolving project needs while maintaining scientific rigor and focus on the end goal.
C-Level
Nterica Bio, inc
“The real challenge in executing a project lies not on how effectively a team can follow a research plan but how well a team can adapt to the evolving needs of the project. Leukocare has proven to be the perfect development partner. Their ability to stay focused on the end goal, adjusting strategies along the way ensures smooth progress and successful outcomes. Their collaborative approach, scientific expertise, and willingness to refine methods as new insights emerge make them an invaluable partner in any development process. With Leukocare, we found a partner who understands that development is a dynamic process!”

C-Level
Nterica Bio, inc
“The real challenge in executing a project lies not on how effectively a team can follow a research plan but how well a team can adapt to the evolving needs of the project. Leukocare has proven to be the perfect development partner. Their ability to stay focused on the end goal, adjusting strategies along the way ensures smooth progress and successful outcomes. Their collaborative approach, scientific expertise, and willingness to refine methods as new insights emerge make them an invaluable partner in any development process. With Leukocare, we found a partner who understands that development is a dynamic process!”

CMC Process Development
TargEd Bio
"Leukocare developed for us a suitable liquid formulation for our complex fusion protein. We were very pleased with the collaboration. Leukocare staff was knowledgeable, responsive, enthousiastic and flexible. The formulation developed yielded a stable fusion protein suitable for use in humans."

CMC Process Dev.
TargEd Bio
"Leukocare developed for us a suitable liquid formulation for our complex fusion protein. We were very pleased with the collaboration. Leukocare staff was knowledgeable, responsive, enthousiastic and flexible. The formulation developed yielded a stable fusion protein suitable for use in humans."

CMC Process Development
TargEd Bio
"Leukocare developed for us a suitable liquid formulation for our complex fusion protein. We were very pleased with the collaboration. Leukocare staff was knowledgeable, responsive, enthousiastic and flexible. The formulation developed yielded a stable fusion protein suitable for use in humans."

Head Drug Product
Incyte
"Leukocare has worked closely with our team, adapting to our processes and timelines. Their flexible and collaborative approach has supported our formulation development well. Their tailored DoE approach has been aligned with our needs and has consistently led to conclusive, science-based results. Their way of working has complemented our internal efforts effectively."

Head Drug Product
Incyte
"Leukocare has worked closely with our team, adapting to our processes and timelines. Their flexible and collaborative approach has supported our formulation development well. Their tailored DoE approach has been aligned with our needs and has consistently led to conclusive, science-based results. Their way of working has complemented our internal efforts effectively."

Head Drug Product
Incyte
"Leukocare has worked closely with our team, adapting to our processes and timelines. Their flexible and collaborative approach has supported our formulation development well. Their tailored DoE approach has been aligned with our needs and has consistently led to conclusive, science-based results. Their way of working has complemented our internal efforts effectively."

Trusted Across the Industry
We are thankful to our partners; amongst others are:
Our Partners






































Quality and Data Integrity at the Core
Quality and Data Integrity at the Core
At Leukocare, quality is not a collection of documents — it is the way we work. Our Quality Management System, aligned with ISO 13485 and ISO 9001, ensures that reliability, compliance, and reproducibility are embedded into every project through standardized processes, rigorous training, and continuous audits.
In parallel, our data science and biostatistics teams act as a second pillar of quality assurance. They safeguard data integrity through automated pipelines that connect data generation, evaluation, and storage, while designing statistically sound experiments and supporting analytical evaluation and shelf-life prediction.
Together, these two pillars create a living approach to quality — combining regulatory strength with data-driven assurance — providing the integrity and transparency our clients need to move forward with confidence.
At Leukocare, quality is not a collection of documents — it is the way we work. Our Quality Management System, aligned with ISO 13485 and ISO 9001, ensures that reliability, compliance, and reproducibility are embedded into every project through standardized processes, rigorous training, and continuous audits.
In parallel, our data science and biostatistics teams act as a second pillar of quality assurance. They safeguard data integrity through automated pipelines that connect data generation, evaluation, and storage, while designing statistically sound experiments and supporting analytical evaluation and shelf-life prediction.
Together, these two pillars create a living approach to quality — combining regulatory strength with data-driven assurance — providing the integrity and transparency our clients need to move forward with confidence.


Let’s Build the Right Formulation — Together
Partner with Leukocare for tailored, data‑driven solutions that bring your biologics closer to patients.


Let’s Build the Right Formulation — Together
Partner with Leukocare for tailored, data‑driven solutions that bring your biologics closer to patients.
